Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway

Study ID: NCT06320951
Start Date: 2026-12-01
End Date: 2029-04-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

Vericiguat 10 MG

Placebo

Insulin Sensitivity Test

Resting Energy and Exercise Energy Expenditure Assessment

White Adipose Tissue Biopsy

MRI-PET Scan for Brown Adipose Tissue Volume Assessment

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Artificial Intelligence-based Methods to Predict Disease Progression in Youth With Type 2 Diabetes

Study ID: NCT07116902
Start Date: 2026-04
End Date: 2026-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

phone application

Standard of Care (SOC)

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

Dialysate Cooling for the Preservation of Cognitive Function in People Receiving Haemodialysis

Study ID: NCT07377500
Start Date: 2026-04-01
End Date: 2028-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

356

Intervention / Treatment

Dialysis cooling

Sponsor

University Hospitals of Derby and Burton NHS Foundation Trust

Source: clinicaltrials.gov

Share:
Add to list

REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapopliteal Artery Disease in Patients With Chronic Limb-threatening Ischemia

Study ID: NCT07270575
Start Date: 2026-04
End Date: 2032-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

Esprit BTK™ Everolimus Eluting Resorbable Scaffold from Abbott

Sponsor

Cardiovascular and Interventional Radiological Society of Europe

Source: clinicaltrials.gov

Share:
Add to list

Epigenetic Factors of Colorectal Adenoma in Korean

Study ID: NCT07366554
Start Date: 2026-02-10
End Date: 2027-05-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

32

Intervention / Treatment
Sponsor

Bundang CHA Hospital

Source: clinicaltrials.gov

Share:
Add to list

Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma

Study ID: NCT07110233
Start Date: 2026-05-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

64

Intervention / Treatment

TheraSphere® Yttrium-90 microspheres

Health Related Quality of Life Questionnaires (HRQOL)

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection

Study ID: NCT07382375
Start Date: 2027-12-31
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Ulinastatin and Thymalfasin

Ulinastatin

Sponsor

Nanjing Medical University

Source: clinicaltrials.gov

Share:
Add to list

Improving the Treatment of Depression Among Youth With HIV

Study ID: NCT07211087
Start Date: 2026-04-15
End Date: 2030-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

130

Intervention / Treatment

COMBEX

COMB

Sponsor

Rhode Island Hospital

Source: clinicaltrials.gov

Share:
Add to list

REmote Physical ACtivity Intervention for High Blood Pressure Postpartum

Study ID: NCT07127731
Start Date: 2027-04
End Date: 2028-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Patient Portal Messaging

FitBit EHR Linkage

Sponsor

Northwestern University

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of Doravirine in the Rapid Initiation

Study ID: NCT07357584
Start Date: 2026-07-13
End Date: 2028-01-13
Study Type

Interventional

Study Phase

Phase4

No. of Participants

100

Intervention / Treatment

Doravirine / lamivudine/ Tenofovir Disoproxil Oral Tablet

Sponsor

Guest Foundation

Source: clinicaltrials.gov

Share:
Add to list